Reducing chronic diseases of lifestyle and managing HIV using an evidence-based approach — what every clinician should know by Visser, ME
The fastest growing epidemics in
the country are those of cardio-
vascular diseases (CVD) and
HIV/AIDS. It is estimated that 7
million people smoke, 7 million
have hypertension, 4 million have
diabetes, 4 million have hyperlipi-
daemia and 4 million are HIV-
positive. Global health authorities
warn that ignoring the emerging
burden of CVD will subvert
efforts to address HIV/AIDS and
other epidemics.
Diet and nutrition are as impor-
tant in the promotion and main-
tenance of good health through-
out life, as they are in the preven-
tion of chronic non-communica-
ble disease.The outcomes of cer-
tain diseases, including HIV and
tuberculosis, are worse when the
host is malnourished, and
micronutrients are known to be
important determinants of infec-
tious disease morbidity.
Evidence-based guidelines for
reducing the risk of cardiovascu-
lar disease by dietary and other
lifestyle practices, as well as
dietary recommendations in the
management of HIV/AIDS, are
underpinned by three principles:
• All individuals can safely fol-
low dietary and lifestyle prac-
tices as a foundation for
achieving and maintaining car-
diovascular and overall health.
• Healthy dietary practices are
based on an overall pattern of
food intake over an extended
period of time and not on a
single meal.
• The guidelines form a frame-
work within which specific
dietary recommendations can
be made for individuals based
on their current status, dietary
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DIABETES
There are currently an estimated
150 million cases of type 2 dia-
betes worldwide and this figure is
expected to double by 2025.This
massive increase is largely due to a
general increase in weight gain,
overweight and obesity and physi-
cal inactivity, particularly in the
industrialised world and in transi-
tional societies. Diabetes is now
being identified at younger ages,
including adolescence and child-
hood, especially in high-risk popu-
lations. The escalating costs of
type 2 diabetes make a strong case
for prevention by dietary m o d i f i c a-
tion and increased physical activity.
Evidence for a healthy lifestyle
in the prevention and treatment
of type 2 diabetes
The evidence for lifestyle factors
increasing the risk of developing
diabetes is shown in Table I. Both
weight and inactivity are indepen-
dent risk factors. Increases in
weight can significantly increase
the risk of developing diabetes.
Abdominal obesity is particularly
important, and waist circumference
or waist/hip ratio are more power-
ful determinants of subsequent
type 2 diabetes than body mass
index (BMI).There is also con-
vincing evidence of increased risk
of infants subsequently developing
diabetes when maternal diabetes or
intrauterine growth retardation
took place.
However, exercise is known to pro-
tect against the development of
type 2 diabetes, even in people
who are overweight.
The dietary picture is far from
clear.Table I outlines the evidence
to date. It appears that a diet high
in saturated fats increases the risk
of impaired glucose tolerance
(IGT) and subsequent progression
to diabetes.
Three cohort studies have shown
that dietary fibre or non-starch
polysaccharides (NSPs) are protec-
tive against the development of
type 2 diabetes, particularly the
soluble type (Table II). Other fac-
tors which have been shown to be
protective, yet which require addi-
tional research, are:
• low total fat intake
• increased intake of omega-3
fatty acids
• foods with a low glycaemic
index  





Prevention and treatment of over-
weight should be a priority, partic-
ularly in high-risk patients. People
should aim for a BMI towards the
lower end of the normal range
(BMI: 21 - 23). Referral to a dietit-
ian is advised as skilled counselling
is needed.
Diet therapy
Patients should be encouraged to
decrease their total consumption of
fat, and particularly of saturated fat
(Table III). Recently there have
been numerous studies showing
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Type of evidence Increased risk of type 2 diabetes Decreased risk of type 2 diabetes
Convincing and accepted Overweight Voluntary weight loss in
by the majority of Obesity overweight and obese





Probable but still Saturated fat Dietary fibre (non-starch
investigating Intrauterine growth polysaccharides (NSPs))
retardation
Insufficient but likely Total fat intake N-3 fatty acids
Trans fatty acids Low glycaemic index foods
Exclusive breast-feeding
Table I. Summary of available level of evidence on lifestyle factors and risk of
developing type 2 diabetes1
The escalating costs
of type 2 diabetes
make a strong case
for prevention by
dietary m o d i f i c a t i o n
and increased physi -
cal activity.
benefits from a high consumption
of omega-3 (N-3) fats and a
decrease in trans fatty acids. The
intake of dietary fibre NSPs should
be encouraged and is achieved
through whole grains, legumes,
vegetables and fruit (Table II).
CARDIOVASCULAR 
DISEASES
Cardiovascular diseases (CVD) are
the main contributor to the global
burden of disease among the non-
communicable diseases.
Evidence for a healthy lifestyle
in the prevention of CVD
The main factors which contribute





The quality of the composition of
dietary fats in the diet strongly
influences the risk of CVDs such
as stroke and coronary heart dis-
ease (CHD) (Table IV). For opti-
mal cardiovascular health, the diet
should be low in saturated fatty
acids (< 7% total energy intake).
Additionally, foods high in myristic
and palmitic acids should be
reduced (Table III), and patients
should be encouraged to read food
labels to avoid these. A very low
intake of trans fatty acids is recom-
mended.
Polyunsaturated fatty acids such as
linoleic acid should comprise 
6 - 10% of the diet with an optimal
ratio of N-6 to N-3 poly-unsaturat-
ed fatty acids at no more that 10 to
1. Monounsaturated fatty acids,
such as oleic acid (found in canola
and olive oil), should make up the
rest of the daily fat. Total fat
intake should not exceed 30% of
energy intake.
Fruits and vegetables
Fruits and vegetables contribute to
a reduced CVD risk through their
potassium, dietary fibre (NSP)
content and phytonutrients. About
500 g per day (5 - 6 servings) is
recommended to reduce the risk of
stroke, high blood pressure and
cardiac arrhythmias.This will also
meet the recommended potassium
intake of 70 - 80 mmol/day.
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Mono- Saturated N-3 poly- N-6 Palmitic Myristic Trans-fatty
unsaturated fatty acids unsaturated poly-unsaturated acid acid acids
fatty acids fatty acids fatty acids
Restrict Restrict
(15 - 30% E*) (< 7% E*) (1 - 2% E*) (5 - 8% E*) (< 1% E*)
Olive oil Butterfat Canola oil Most vegetable Palm oil Butterfat Margarine 
oils and short-
ening which is 
hydrogenated
(hardened)
Canola oil Coconut oil Flaxseed oil Animal fat Coconut oil Full-cream 
dairy products 
Nuts Palm oil Soy oil Confectio- Confectio- Meat fat/lard
nary nary
Avocado Fatty marine fish Non-dairy Non-dairy
creamers creamers
Peanuts/oil Peanut oil Walnuts Deep fat fried 
foods
Animal fat Green leafy Baked goods
vegetables with margarine
Soybeans or shortening 
of the hard 
type
* Recommended proportion of total dietary energy intake.
Table III. Sources of fats and oils in the diet
Type of fibre Good sources of fibre
Soluble fibre Oats, legumes (dry beans, dry peas), apples, pears, 
peas and other fruits and vegetables
Insoluble fibre Bran, whole grains, wholewheat flour products, fruits 
and vegetables, edible seeds e.g. strawberries
Table II. Sources of fibre in the diet
Salt (sodium)
Sodium from all sources should be
limited in order to reduce blood
pressure levels. Current evidence
recommends a sodium intake of
less than 1.7 g/day. To meet this
goal, daily salt should be restricted
to less than 5 g (1 teaspoon) per
day. All sources of sodium are
included in this recommendation,
including MSG and preservatives,
frequently found in items such as
stock cubes and ‘flavoured’ salts.
Alcohol
Although a low consumption of
alcohol is protective against CHD,
other health risks associated with
alcohol consumption do not favour
a general recommendation.
Physical activity
At least 30 minutes of moderate-
intensity exercise, e.g. brisk walk-
ing on most days of the week, is
considered sufficient, although
lower limits are still ill-defined.
HIV/AIDS
HIV/AIDS is a major public health
problem worldwide, but particular-
ly in sub-Saharan Africa where it
poses a major threat to household
food security by means of dimin-
ished food production, as well as
the inability to purchase food.
Evidence for the role of nutri-
tional factors in the treatment of
HIV/AIDS
Studies have shown that weight
loss predicts morbidity and mortal-
ity in persons living with
HIV/AIDS (PLWHA).
Micronutrient deficiencies may
also occur, the signs and symptoms
of which are often lacking.
Epidemiological evidence indicates
that low dietary intakes of several
vitamins and minerals may be
associated with increased HIV dis-
ease progression and/or mortality.
As a result, the role of micronutr i-
ents in HIV/AIDS takes on special
importance in populations with
marginal intakes. Few randomised
clinical trials evaluating the efficacy
of micronutrient interventions in
PLWHA have been conducted.
The current evidence on the role
of micronutrients in host defence
and HIV infection was recently
summarised (Table V).
Limited evidence indicates that
dietary counselling is an effective
method to restore the energy and
nutrient intake of PLWHA. In
industrialised countries high-ener-
gy, high-protein nutritional supple-
ments often form part of the nutri-
tional management of PLWHA.
However, few studies have evaluat-
ed the effects of supplemental
nutrition. An increase in body
weight has been documented in
some intervention studies, but not
in others. In many of these studies
the increases in body weight com-
prised body fat and not lean body
mass. Thus, many authors con-
cluded that simply providing nutr i-
ents to a malnourished patient is
inadequate and attention moved to
the use of anabolic agents, such as
recombinant growth hormone in
the treatment of malnutrition.
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Type of evidence Increased risk of CVD Decreased risk of CVD
Convincing and accepted Myristic and palmitic acids Fruits and vegetables
by the majority of medical Fish and fish oils (EPA
scientists Trans fatty acids and DHA)
High sodium intake Potassium
Overweight/obesity Linoleic acid (LA)
High alcohol intake (for stroke) Regular physical activity
Low - moderate alcohol intake
Probable but still investigating Dietary cholesterol Alpha-linoleic acid (ALA)
Unfiltered boiled coffee Oleic acid





Insufficient but likely Fats rich in lauric acid Flavonoids
Impaired fetal nutrition Soy products








increased HIV dis -
ease progression
and/or mortality.
Because of underlying factors con-
tributing to poor baseline nutri-
tion, nutritional care and support
of PLWHA may be more impor-
tant in developing countries.
However, the extent to which
nutritional therapy can reverse
weight loss among PLWHA in
Africa is largely unknown. The
impact of nutritional inter ventions
on body composition appears to be
most effective during early rather
than later stages of HIV infection.
Early treatment for infections is
probably one of the most effective
ways of conserving the nutritional
status of people living with HIV, as
nutritional therapies fail without
treatment of the underlying infec-
tion.
Evidence suggests that aerobic
exercise is safe for PLWHA who
are medically stable. Regular aero-
bic exercise results in an increased
CD4 count, improved cardiopul-
monary fitness and psychological
well-being. Further research is
required to investigate the effects
of aerobic exercise in people at
varying stages of HIV disease, par-




Nutritional support for people with
HIV should be provided in a holis-
tic manner. The recommendations
of a WHO expert consultation on
the dietary and nutrient require-
ments for people living with
HIV/AIDS are awaited.
Dietary counselling
Guides for nutrition counselling
and support of HIV-affected
households are available and pro-
vide practical recommendations to
health workers on how to achieve
healthy nutrition. Key messages
include:
• start early
• choose your food according to
your own tastes
• eat a variety of foods 
• make starchy foods the basis of
each meal
• eat lots of fruit and vegetables 
• meat and dairy products may be
eaten daily
• eat dried beans, peas, lentils,
peanuts or soya regularly
• include sugars, fats and oils,
especially after periods of weight
loss
• use salt sparingly
• be as active as you can
• drink lots of clean, safe water.
Practical dietary advice for easing
the symptoms of HIV/AIDS is also
provided.
Micronutrient supplements
It is likely that daily micronutrient
supplements will be required to
reverse underlying deficiencies of
HIV-infected populations, especial-
ly in developing countries. Few
authors have attempted to formu-
late recommendations for the sup-
plementation of micronutrients to
HIV/AIDS patients. Some recom-
mend the supplementation of vita-
min A, along with antioxidants
such as b-carotene, vitamin E, C
and selenium. Others have con-
cluded that the supplementation of
twice the Recommended Daily
Allowance (RDA) for most
micronutrients is likely to be bene-
ficial for the majority of HIV-
infected individuals in Africa, since
a range of micronutrient deficien-
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Immune functions Replication Viral load Progression/ mortality Transmission
Vitamin A ≠ ≠ ≠ . ~ Ø (Ø)
B vitamins ≠ ≠ ? ? (Ø) ?
Vitamin C ≠ Ø (Ø) ? ?
Vitamin E ≠ ≠ Ø (Ø) ? ?
Iron ≠ ≠ ? (≠ ) ?
Zinc ≠ ≠ ≠ . ? (≠ ) ?
Selenium ≠ Ø (~) (≠ ) ?
≠ , ≠≠ , ≠ ≠ ≠: slight, moderate, considerable increase
Ø, ØØ, ØØØ: slight, moderate, considerable decrease
.: increase or decrease
~: no effect
?: not known 
( ): only weak or observational data
Table V. Current evidence of the role of micronutrients in HIV infection2
Early treatment for
infections is proba -






therapies fail with -
out treatment of the
u n d e r l y i n g
i n f e c t i o n .
cies usually co-exists. However,
iron supplements should not be
administered during opportunistic
infections. For the management of
HIV-infected children, the WHO
guidelines for micronutrient sup-
plementation in children with
severe malnutrition may be used,
comprising a standard multivita-
min and mineral mixture. In addi-
tion, high-dose vitamin A supple-
mentation should be provided.
Physical exercise
HIV-infected individuals who are
medically stable may perform aero-
bic exercise for at least 20 minutes,
three times a week.
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IN A NUTSHELL
Prevention/treatment of overweight
should be a priority, particularly in
high-risk patients, in order to reduce
the risk of type 2 diabetes and CVD.
Patients should decrease their total
consumption of fat, particularly satu-
rated fat, trans fatty acids, as well as
myristic and palmitic acids.
About 5 - 6 servings of fruit and veg-
etables per day are recommended
to reduce CVD risk. 
Regular fish consumption (1 - 2 serv-
ings per week) is protective against
CHD. 
Salt intake should be restricted to
less than 1 teaspoon per day from
all dietary sources.
At least 30 minutes of moderate-
intensity exercise, e.g. brisk walking
on most days of the week, is consid-
ered sufficient to reduce CVD risk.
Dietary counselling is an effective
method to encourage PLWHA to
restore their energy and nutrient
intake, especially during early dis-
ease.
It is likely that PLWHA will require
micronutrient supplementation to
reverse underlying deficiencies.
Early treatment for infections is an
effective way of conserving the nutri-
tional status of PLWHA.
Aerobic exercise appears to be safe
for PLWHA who are medically s table. 
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SINGLE SUTURE
Mortality associated with concomitant ibuprofen and aspirin in
patients with cardiovascular disease
In January 2002 it was reported that scientists showed that ibupro-
fen blocks aspirin’s inhibition of platelet aggregation.This has been
supported by a UK-based study of more than 7 000 patients with
coronary heart disease who were discharged from hospital on low-
dose aspirin. It was found that compared with single-aspirin thera-
py (i) patients receiving the combination of aspirin and ibuprofen
experienced almost double the risk of all-cause mortality, and an
increased risk in cardiovascular mortality of approximately 75%
was reported; and (ii) for persons prescribed aspirin in combination
with other NSAIDs, e.g. diclofenac, there was no increased mortali-
ty risk. It is reported that although this evidence may be inconclu-
sive, the authors of the study support the hypothesis that combina-
tion treatment for secondary prevention with ibuprofen and aspirin
may be harmful owing to a possible antagonisation of aspirin’s car-
dioprotective effects.
(The Pharmaceutical Journal 2003; 270: 217.) 
